Award
CanadaBuys #W6369-20A009/001/PH
Anthrax Vaccine - Biothrax
Recipient
Emergent BioDefense Operations Lansing
Award Amount
$36,996,123.20
Ceiling
$36,996,123.20
Awarded
October 25, 2019
Identifier
W6369-20A009/001/PH
A contract awarded to Emergent BioDefense Operations Lansing for the supply of Anthrax Vaccine - Biothrax with a total value of CAD 36,996,123.20, effective from October 25, 2019, to March 31, 2030.
Description
Contract for Anthrax Vaccine - Biothrax awarded to Emergent BioDefense Operations Lansing.